文献速递中医内科针灸推拿中药与中成药合理使用

针灸与中药辅助标准治疗促进重症COVID-19患者康复

Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care.
PubMed 文献 · J Integr Med · 2021-06-08

本文报告一例武汉雷神山医院老年女性重症COVID-19患者,在标准治疗基础上接受手动针灸、中药颗粒剂「扶正救肺」及血必净注射液辅助治疗。监测呼吸频率、SpO2、心率、NLR、MLR、CRP及胸部CT,针灸显著改善呼吸功能、提高SpO2并降低心率,中药可能稳定针灸疗效并加速肺部感染病灶吸收。联合治疗使NLR从14.14降至5.83,MLR从1.15降至0.33,CRP从15.25降至6.01 mg/L。

要点

  • 针灸可显著改善重症COVID-19患者呼吸功能、提高SpO2并降低心率。
  • 中药可能稳定针灸疗效,加量后似可加速肺部感染病灶吸收。
  • 针灸联合中药可降低NLR、MLR及CRP,提示辅助标准治疗可能获益。

核心结论

  • 针灸与中药作为标准治疗的辅助手段,可能对重症COVID-19病例取得更好疗效。

研究设计与样本

  • 单例病例报告,对象为武汉雷神山医院一例老年女性重症COVID-19患者。

主要发现

  • 针灸显著改善患者呼吸功能、提高SpO2并降低心率。
  • 中药可能使针灸效果更稳定,加量后似加速肺部感染病灶吸收。
  • 联合治疗使NLR从14.14降至5.83、MLR从1.15降至0.33、CRP从15.25降至6.01 mg/L。

关键数值与推荐

  • 监测指标包括呼吸频率、SpO2、心率、NLR、MLR、CRP及胸部CT。
  • 干预包括手动针灸、中药颗粒剂「扶正救肺」及血必净注射液,均附加于标准治疗。

临床怎么用

  • 重症COVID-19可在标准治疗基础上考虑针灸与中药辅助,并动态监测SpO2、心率及炎症指标。
  • 中药剂量调整可能影响肺部病灶吸收速度,需结合影像与炎症指标评估。

局限性

  • 为单例病例报告,不能确立因果关系或推广至其他患者。
  • 原文未报告样本量、P值、置信区间等统计量,疗效判断需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is currently no drug or therapy that can cure the coronavirus disease 2019 (COVID-19), which is highly contagious and can be life-threatening in severe cases. Therefore, seeking potential effective therapies is an urgent task. An older female at the Leishenshan Hospital in Wuhan, China, with a severe case of COVID-19 with significant shortness of breath and decrease in peripheral oxygen saturation (SpO2), was treated using manual acupuncture and Chinese herbal medicine granule formula Fuzheng Rescue Lung with Xuebijing Injection in addition to standard care. The patient's breath rate, SpO2, heart rate, ratio of neutrophil/lymphocyte (NLR), ratio of monocyte/lymphocyte (MLR), C-reactive protein (CRP), and chest computed tomography were monitored. Acupuncture significantly improved the patient's breathing function, increased SpO2, and decreased her heart rate. Chinese herbal medicine might make the effect of acupuncture more stable; the use of herbal medicine also seemed to accelerate the absorption of lung infection lesions when its dosage was increased. The combination of acupuncture and herbs decreased NLR from 14.14 to 5.83, MLR from 1.15 to 0.33 and CRP from 15.25 to 6.01 mg/L. These results indicate that acupuncture and Chinese herbal medicine, as adjuvants to standard care, might achieve better results in treating severe cases of COVID-19.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Yin X, Cai SB, Tao LT, et al. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care. J Integr Med. 2021. PMID: 34154967. doi:10.1016/j.joim.2021.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。